NorthStar Medical Radioisotopes, LLC

NorthStar Medical Radioisotopes, LLC is dedicated to providing global access to game-changing radiopharmaceuticals, focused on advancing patient care through therapeutic radioisotopes and novel radiopharmaceuticals used to detect and treat cancer. With a commitment to innovation, NorthStar Medical Radioisotopes, LLC is positioned as a key player in the rapidly evolving field of radiopharmaceutical therapy.

Operating from its primary address at 1800 Gateway Boulevard, Beloit, Wisconsin 53511, US, and with additional locations at 5249 Femrite Drive, Madison, Wisconsin 53718, US; 1601 South Providence Road, Columbia, Missouri 65211, US; and 3060 Progress Rd, Madison, Wisconsin 53716, US, NorthStar Medical Radioisotopes, LLC is expanding its industry-leading position by developing commercial-scale production technologies. The company routinely produces copper-67 (Cu-67) and is preparing to be a leading commercial-scale producer of non-carrier-added (n.c.a.) actinium-225 (Ac-225), utilizing first-in-kind and environmentally preferable electron accelerator technology.

NorthStar Medical Radioisotopes, LLC also features a Radiopharmaceutical Contract Development and Manufacturing Organization (CMDO/CMO) unit, providing customized service offerings and specialized radiopharmaceutical expertise to help biopharmaceutical companies advance their development and commercial programs. NorthStar Medical Radioisotopes, LLC is committed to continuous innovation and excellence in radiopharmaceutical development and manufacturing. We invite the management of NorthStar Medical Radioisotopes, LLC to create a customized and exclusive company showcase and product listing on our platform.